Differential expression of Fas family members and Bcl-2 family members in benign versus malignant epithelial ovarian cancer (EOC) in North Indian population

Molecular and Cellular Biochemistry

Volumn 368, Issue 1-2, 2012, Pages 119-126

  Chaudhry, Parvesh ^a   Srinivasan, Radhika ^a   Patel, Firuza D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apoptosis; Bcl 2 family; Epithelial ovarian cancer; Fas family

Indexed keywords

FAP 1 PROTEIN; FAS ANTIGEN; FAS LIGAND; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG;

AMERICAN INDIAN; ARTICLE; BENIGN TUMOR; CANCER GROWTH; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; OVARY CARCINOMA; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD95; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIA; OVARIAN NEOPLASMS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 13; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 84864342304     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1350-7     Document Type: Article

References (24)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ (2004) Cancer statistics, 2004. CA Cancer J Clin 54:8-29 (Pubitemid 38443417)
2. Seidman JD, Russell P, Kurman RJ (2002) Surface epithelial tumors of the ovary. In: Kurman RJ (ed) Blaustein's pathology of the female genital tract, 5th edn. Springer, New York, pp 791-904
3. Meyer T, Rustin GJ (2000) Role oftumour markers in monitoring epithelial ovarian cancer. Br J Cancer 82:1535-1538 (Pubitemid 30204358)
4. Reed CJ (2000) Apoptosis and cancer: strategies for integrating programmed cell death. Semin Hematol 37:9-16
5. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A (2000) Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12:611-620
6. Sato T, Irie S, Kitada S, Reed JC (1995) FAP-1: aproteintyrosine phosphatase that associates with Fas. Science 268:411-415
7. Ungefroren H, Kruse ML, Trauzold A, Roeschmann S, Roeder C, Arlt A, Henne-Bruns D, Kalthoff H (2001) FAP-1 in pancreatic cancer cells: functional and mechanistic studies on its inhibitory role in CD95-mediated apoptosis. J Cell Sci 114:2735-2746 (Pubitemid 32785453)
8. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647-656. doi: 10.1038/nrc883nrc883 (Pubitemid 37328916)
9. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219 (Pubitemid 38167313)
10. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBOJ23:2134-2145. doi:10.1038/ sjemboj7600210 (Pubitemid 38737740)
11. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312-1316 (Pubitemid 28406817)
12. Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R (2000) Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endome-trial carcinomas using real-time quantitative RT-PCR. Br J Cancer 82:1682-1688. doi:10.1054/bjoc.2000.1118 (Pubitemid 30229579)
13. van Haaften-Day C, Russell P, Davies S, King NJ, Tattersall MH (2003) Expression of Fas and Fas L in human serous ovarian epithelial tumors. Hum Pathol 34:74-79. doi:10.1053/hupa. 2003.7 (Pubitemid 36160024)
14. Ben-Hur H, Gurevich P, Huszar M, Ben-Arie A, Berman V, Tendler Y, Tchanishev R, Zinder O, Mor G, Zaltsman Y, Kohen F, Zusman I (1999) Apoptosis and apoptosis-related proteins in the epithelium of human ovarian tumors: immunohistochemical and morphometric studies. Eur J Gynaecol Oncol 20:249-253 (Pubitemid 30113720)
15. Zusman I, Gurevich P, Gurevich E, Ben-Hur H (2001) The immune system, apoptosis and apoptosis-related proteins in human ovarian tumors (a review). Int J Oncol 18:965-972
16. Munakata S, Enomoto T, Tsujimoto M, Otsuki Y, Miwa H, Kanno H, Aozasa K (2000) Expressions of Fas ligand and other apoptosis-related genes and their prognostic significance in epi-thelial ovarian neoplasms. Br J Cancer 82:1446-1452 (Pubitemid 30175912)
17. Meinhold-Heerlein I, Stenner-Liewen F, Liewen H, Kitada S, Krajewska M, Krajewski S, Zapata JM, Monks A, Scudiero DA, Bauknecht T, Reed JC (2001) Expression and potential role of Fas-associated phosphatase-1 in ovarian cancer. Am J Pathol 158:1335-1344. doi:10.1016/S0002-9440(10)64084-9 (Pubitemid 32281297)
18. Marone M, Scambia G, Mozzetti S, Ferrandina G, Iacovella S, De Pasqua A, Benedetti-Panici P, Mancuso S (1998) bcl-2, bax, bcl-XL, and bcl-XS expression in normal and neoplastic ovarian tissues. Clin Cancer Res 4:517-524 (Pubitemid 28122771)
19. Shigemasa K, Katoh O, Shiroyama Y, Mihara S, Mukai K, Nagai N, Ohama K (2002) Increased MCL-1 expression is associated with poor prognosis in ovarian carcinomas. Jpn J Cancer Res 93: 542-550 (Pubitemid 34752911)
20. Wehrli BM, Krajewski S, Gascoyne RD, Reed JC, Gilks CB (1998) Immunohistochemical analysis ofbcl-2, bax, mcl-1, and bcl-X expression in ovarian surface epithelial tumors. Int J Gynecol Pathol 17:255-260 (Pubitemid 28299740)
21. Chan WY, Cheung KK, Schorge JO, Huang LW, Welch WR, Bell DA, Berkowitz RS, Mok SC (2000) Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol 156:409-417. doi:10.1016/S0002-9440(10)64744-X (Pubitemid 30643795)
22. Miyamoto Y, Hosotani R, Wada M, Lee JU, Koshiba T, Fujimoto K, Tsuji S, Nakajima S, Doi R, Kato M, Shimada Y, Imamura M (1999) Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 56:73-82 (Pubitemid 29043900)
23. Arts HJ, de Jong S, Hollema H, Ten Hoor KA, de Vries EG, van der Zee AG (2005) Fas and Fas ligand in cyst fluids, serum and tumors of patients with benign and (borderline) malignant ovarian tumors. Int J Oncol 26:379-384
24. Fauvet R, Dufournet C, Poncelet C, Uzan C, Hugol D, Darai E (2005) Expression of pro-apoptotic (p53, p21, bax, bak and fas) and anti-apoptotic (bcl-2 and bcl-x) proteins in serous versus mucinous borderline ovarian tumours. J Surg Oncol 92:337-343. doi:10.1002/jso.20424 (Pubitemid 41779293)